Cargando…

Procurement and use of social determinants of health data among key health care stakeholders

BACKGROUND: A growing body of evidence supports the need for health systems to shift towards addressing social determinants of health (SDoH) as part of routine care. However, little is known about the state of the industry in terms of procurement and use of SDoH data. OBJECTIVES: To assess stakehold...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidari, Elham, Brown, Carolyn, Johnsrud, Michael, Mastrangelo, Vittorio, Spears, Asya, Parikh, Megha, Campbell, Patrick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373048/
https://www.ncbi.nlm.nih.gov/pubmed/35471072
http://dx.doi.org/10.18553/jmcp.2022.28.5.538
_version_ 1785078482699550720
author Heidari, Elham
Brown, Carolyn
Johnsrud, Michael
Mastrangelo, Vittorio
Spears, Asya
Parikh, Megha
Campbell, Patrick J.
author_facet Heidari, Elham
Brown, Carolyn
Johnsrud, Michael
Mastrangelo, Vittorio
Spears, Asya
Parikh, Megha
Campbell, Patrick J.
author_sort Heidari, Elham
collection PubMed
description BACKGROUND: A growing body of evidence supports the need for health systems to shift towards addressing social determinants of health (SDoH) as part of routine care. However, little is known about the state of the industry in terms of procurement and use of SDoH data. OBJECTIVES: To assess stakeholders’ perceptions and experiences in collecting and utilizing SDoH data. METHODS: A prospective, cross-sectional study was conducted using a 24-item electronic survey. The pilot-tested survey was distributed to a diverse convenience sample of 94 health care stakeholder organizations that are members of the Pharmacy Quality Alliance organization. Survey responses were collected from November to December 2020. Descriptive statistics were used to analyze responses. RESULTS: A total of 25 respondents completed the survey (response rate = 26.6%). More than half (n = 14, 56.0%) collected and tracked SDoH data, and of those, most (n = 6, 42.85%) reported using organization-specific tools instead of standardized SDoH tools. Economic stability and health and health care indicators were the most frequently identified types of SDoH data collected. Participants reported that both identifying (mean = 3.88 ± SD = 0.88; 1 = not important to 5 = extremely important) and addressing (3.88 ± 0.93) patients’ SDoH were moderately important to their organization. Lack of standard data format (72.0%), lack of time (52.0%), and lack of technological capabilities (44.0%) were the most commonly reported barriers to collecting SDoH data. However, value-based payment programs that reward addressing SDoH needs (76.0%) and a coding structure or reimbursement mechanism for identification and management of SDoH (60.0%) were most commonly reported as mechanisms to overcome SDoH data collection barriers. CONCLUSIONS: Health care stakeholders consider patient SDoH indicators important but report significant challenges in collecting these data. Solutions that address data standardization, time burden, technological barriers, and the offering of incentives could facilitate its collection and effective use.
format Online
Article
Text
id pubmed-10373048
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103730482023-07-31 Procurement and use of social determinants of health data among key health care stakeholders Heidari, Elham Brown, Carolyn Johnsrud, Michael Mastrangelo, Vittorio Spears, Asya Parikh, Megha Campbell, Patrick J. J Manag Care Spec Pharm Research Brief BACKGROUND: A growing body of evidence supports the need for health systems to shift towards addressing social determinants of health (SDoH) as part of routine care. However, little is known about the state of the industry in terms of procurement and use of SDoH data. OBJECTIVES: To assess stakeholders’ perceptions and experiences in collecting and utilizing SDoH data. METHODS: A prospective, cross-sectional study was conducted using a 24-item electronic survey. The pilot-tested survey was distributed to a diverse convenience sample of 94 health care stakeholder organizations that are members of the Pharmacy Quality Alliance organization. Survey responses were collected from November to December 2020. Descriptive statistics were used to analyze responses. RESULTS: A total of 25 respondents completed the survey (response rate = 26.6%). More than half (n = 14, 56.0%) collected and tracked SDoH data, and of those, most (n = 6, 42.85%) reported using organization-specific tools instead of standardized SDoH tools. Economic stability and health and health care indicators were the most frequently identified types of SDoH data collected. Participants reported that both identifying (mean = 3.88 ± SD = 0.88; 1 = not important to 5 = extremely important) and addressing (3.88 ± 0.93) patients’ SDoH were moderately important to their organization. Lack of standard data format (72.0%), lack of time (52.0%), and lack of technological capabilities (44.0%) were the most commonly reported barriers to collecting SDoH data. However, value-based payment programs that reward addressing SDoH needs (76.0%) and a coding structure or reimbursement mechanism for identification and management of SDoH (60.0%) were most commonly reported as mechanisms to overcome SDoH data collection barriers. CONCLUSIONS: Health care stakeholders consider patient SDoH indicators important but report significant challenges in collecting these data. Solutions that address data standardization, time burden, technological barriers, and the offering of incentives could facilitate its collection and effective use. Academy of Managed Care Pharmacy 2022-05 /pmc/articles/PMC10373048/ /pubmed/35471072 http://dx.doi.org/10.18553/jmcp.2022.28.5.538 Text en Copyright © 2022, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Brief
Heidari, Elham
Brown, Carolyn
Johnsrud, Michael
Mastrangelo, Vittorio
Spears, Asya
Parikh, Megha
Campbell, Patrick J.
Procurement and use of social determinants of health data among key health care stakeholders
title Procurement and use of social determinants of health data among key health care stakeholders
title_full Procurement and use of social determinants of health data among key health care stakeholders
title_fullStr Procurement and use of social determinants of health data among key health care stakeholders
title_full_unstemmed Procurement and use of social determinants of health data among key health care stakeholders
title_short Procurement and use of social determinants of health data among key health care stakeholders
title_sort procurement and use of social determinants of health data among key health care stakeholders
topic Research Brief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373048/
https://www.ncbi.nlm.nih.gov/pubmed/35471072
http://dx.doi.org/10.18553/jmcp.2022.28.5.538
work_keys_str_mv AT heidarielham procurementanduseofsocialdeterminantsofhealthdataamongkeyhealthcarestakeholders
AT browncarolyn procurementanduseofsocialdeterminantsofhealthdataamongkeyhealthcarestakeholders
AT johnsrudmichael procurementanduseofsocialdeterminantsofhealthdataamongkeyhealthcarestakeholders
AT mastrangelovittorio procurementanduseofsocialdeterminantsofhealthdataamongkeyhealthcarestakeholders
AT spearsasya procurementanduseofsocialdeterminantsofhealthdataamongkeyhealthcarestakeholders
AT parikhmegha procurementanduseofsocialdeterminantsofhealthdataamongkeyhealthcarestakeholders
AT campbellpatrickj procurementanduseofsocialdeterminantsofhealthdataamongkeyhealthcarestakeholders